Cyclin D1 is overexpressed in 50% of breast cancers [14], and at lower frequencies in many other cancers including prostate cancer [15]; while Cyclin E has been reported to be deregulated in malignant tumors of the lung, breast, gastrointestinal tract and in ovarian cancer [16]. Here, CCND1 is linked to breast cancer.